4.5 Review

Imaging Heterogeneity in Lung Cancer: Techniques, Applications, and Challenges

期刊

AMERICAN JOURNAL OF ROENTGENOLOGY
卷 207, 期 3, 页码 534-543

出版社

AMER ROENTGEN RAY SOC
DOI: 10.2214/AJR.15.15864

关键词

heterogeneity; informatics; lung cancer; radiogenomics; radiomics; texture analysis

资金

  1. Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre awards
  2. Cancer Research UK
  3. Engineering and Physical Sciences Research Council in association
  4. Medical Research Council
  5. Department of Health (England)
  6. Cancer Research UK [16463] Funding Source: researchfish

向作者/读者索取更多资源

OBJECTIVE. Texture analysis involves the mathematic processing of medical images to derive sets of numeric quantities that measure heterogeneity. Studies on lung cancer have shown that texture analysis may have a role in characterizing tumors and predicting patient outcome. This article outlines the mathematic basis of and the most recent literature on texture analysis in lung cancer imaging. We also describe the challenges facing the clinical implementation of texture analysis. CONCLUSION. Texture analysis of lung cancer images has been applied successfully to FDG PET and CT scans. Different texture parameters have been shown to be predictive of the nature of disease and of patient outcome. In general, it appears that more heterogeneous tumors on imaging tend to be more aggressive and to be associated with poorer outcomes and that tumor heterogeneity on imaging decreases with treatment. Despite these promising results, there is a large variation in the reported data and strengths of association.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Tumor Physiology and Clinically Significant Prostate Cancer Detection

Vicky Goh

RADIOLOGY (2023)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Research should remain a priority in 21st century radiology recruitment to training

Paul Jenkins, Indrajeet Mandal, Jim Zhong, Vicky Goh

Summary: Research in Clinical Radiology is facing challenges due to increased clinical demand, workforce shortages, and lack of funding and protected research time. The 2023 radiology specialty application process prioritizes other domains like audit over research, which is concerning considering the lack of research culture within the specialty. To strengthen research within radiology training, attracting bright candidates and ensuring research remains a priority is crucial for the future radiology workforce.

BRITISH JOURNAL OF RADIOLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Academic clinical fellows in radiology: how can we improve success?

T. D. Turmezei, S. C. Shelmerdine, A. H. Ashok, V. Goh

Summary: This study surveyed past and current radiology academic clinical fellows (ACFs) to gather feedback on their experiences, academic achievements, challenges in balancing academic and clinical responsibilities, and suggestions for optimizing the fellowship program. The results showed that many ACFs continue their academic interests after training, with some achieving higher research degrees. Balancing clinical workload was identified as a challenge, requiring flexibility from supervisors.

CLINICAL RADIOLOGY (2023)

Review Radiology, Nuclear Medicine & Medical Imaging

Input function and modeling for determining bone metabolic flux using [18F] sodium fluoride PET imaging: A step-by-step guide

Tanuj Puri, Michelle L. Frost, Amelia E. B. Moore, Gary J. R. Cook, Glen M. Blake

Summary: This article introduces the method of measuring bone metabolic flux (K-i) using [F-18] sodium fluoride ([F-18]NaF) positron emission tomography (PET) scans, and proposes a simplified method that estimates K-i values from static scans and venous blood samples. By reviewing different methods of measuring arterial input functions (AIF), a non-invasive method for studying bone metabolism without arterial blood sampling is provided, which shortens scan times, simplifies procedures, and reduces costs.

MEDICAL PHYSICS (2023)

Article Oncology

Association of dynamic contrast-enhanced MRI an Fluorodeoxyglucose PET/CT parameters with neoadjuvant therapy response and survival in esophagogastric cancer d 18F-

Samuel J. Withey, Kasia Owczarczyk, Mariusz T. Grzeda, Connie Yip, Harriet Deere, Mike Green, Nick Maisey, Andrew R. Davies, Gary J. Cook, Vicky Goh

Summary: This study found that pre-treatment vascular and metabolic parameters of esophagogastric tumors may be associated with response to neoadjuvant therapy. However, these parameters showed no significant relationship with survival.
Article Oncology

Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

Janet E. Brown, Kara-Louise Royle, Walter Gregory, Christy Ralph, Anthony Maraveyas, Omar Din, Timothy Eisen, Paul Nathan, Tom Powles, Richard Griffiths, Robert Jones, Naveen Vasudev, Matthew Wheater, Abdel Hamid, Tom Waddell, Rhona McMenemin, Poulam Patel, James Larkin, Guy Faust, Adam Martin, Jayne Swain, Janine Bestall, Christopher McCabe, David Meads, Vicky Goh, Tze Min Wah, Julia Brown, Jenny Hewison, Peter Selby, Fiona Collinson

Summary: This study aimed to compare the non-inferiority of a tyrosine kinase inhibitor drug-free interval strategy with a conventional continuation strategy in the first-line treatment of advanced clear cell renal cell carcinoma. The results showed that non-inferiority between the two groups could not be concluded in terms of overall survival and quality-adjusted life-years (QALYs). However, treatment breaks might be a feasible and cost-effective option with lifestyle benefits for patients during tyrosine kinase inhibitor therapy in patients with renal cell carcinoma.

LANCET ONCOLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

[99mTc]-labelled anti-Programmed Death-Ligand 1 single-domain antibody SPECT/CT: a novel imaging biomarker for myocardial PD-L1 expression

Muhummad Sohaib Nazir, Daniel Johnathan Hughes, Gitasha Chand, Kathryn Adamson, Jessica Johnson, Damion Bailey, Victoria Gibson, Hong Hoi Ting, Alexander Lyon, Gary J. R. Cook

Summary: This study determines a non-invasive method for assessing myocardial PD-L1 expression using [Tc-99m]-labelled anti-PD-L1 single-domain antibody (NM-01) SPECT/CT. The study finds that myocardial PD-L1 expression is higher than skeletal muscle in lung cancer patients, and this technique has high reliability and specificity. It can be applied to investigate ICI-associated myocarditis and cardiomyopathies.

EJNMMI RESEARCH (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Inter-rater and intra-rater agreement of [Tc-99m]-labelled NM-01, a single-domain programmed death-ligand 1 (PD-L1) antibody, using quantitative SPECT/CT in non-small cell lung cancer

Daniel Johnathan Hughes, Gitasha Chand, Jessica Johnson, Damion Bailey, Kathryn Adamson, Vicky Goh, Gary J. R. Cook

Summary: This study aims to determine the inter- and intra-rater agreement of the quantitative measurement of [Tc-99m]NM-01 SPECT/CT in NSCLC. The results show that using SUVmax and malignant lesion-to-blood pool ratios can provide accurate assessment of NSCLC. This study validates the effectiveness of [Tc-99m]NM-01 SPECT/CT in NSCLC.

EJNMMI RESEARCH (2023)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

NIHR Imaging Group. Who are we and what do we do?

S. A. Taylor, A. Darekar, V. Goh, S. Neubauer, A. Rockall, J. Solomon

CLINICAL RADIOLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Development and Evaluation of Machine Learning in Whole-Body Magnetic Resonance Imaging for Detecting Metastases in Patients With Lung or Colon Cancer

Andrea G. Rockall, Xingfeng Li, Nicholas Johnson, Ioannis Lavdas, Shalini Santhakumaran, A. Toby Prevost, Shonit Punwani, Vicky Goh, Tara D. Barwick, Nishat Bharwani, Amandeep Sandhu, Harbir Sidhu, Andrew Plumb, James Burn, Aisling Fagan, Georg J. Wengert, Dow-Mu Koh, Krystyna Reczko, Qi Dou, Jane Warwick, Xinxue Liu, Christina Messiou, Nina Tunariu, Peter Boavida, Neil Soneji, Edward W. Johnston, Christian Kelly-Morland, Katja N. De Paepe, Heminder Sokhi, Kathryn Wallitt, Amish Lakhani, James Russell, Miriam Salib, Sarah Vinnicombe, Adam Haq, Eric O. Aboagye, Stuart Taylor, Ben Glocker

Summary: The study aimed to develop a machine learning algorithm to improve radiologists' sensitivity and specificity for metastasis detection in whole-body magnetic resonance imaging (WB-MRI). The results showed that using the algorithm can enhance the detection accuracy and reduce reading times for radiologists.

INVESTIGATIVE RADIOLOGY (2023)

Article Oncology

Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom

Jonathan L. Moore, Michael Green, Aida Santaolalla, Harriet Deere, Richard P. T. Evans, Mona Elshafie, Anita Lavery, Damian T. McManus, Andrew McGuigan, Rosalie Douglas, Joanne Horne, Robert Walker, Hira Mir, Monica Terlizzo, Sivesh K. Kamarajah, Mieke Van Hemelrijck, Nick Maisey, Ailsa Sita-Lumsden, Sarah Ngan, Mark Kelly, Cara R. Baker, Sacheen Kumar, Jesper Lagergren, William H. Allum, James A. Gossage, Ewen A. Griffiths, Heike I. Grabsch, Richard C. Turkington, Tim J. Underwood, Elizabeth C. Smyth, Rebecca C. Fitzgerald, David Cunningham, Andrew R. Davies

Summary: This study aimed to evaluate the influence of lymph node (LN) regression on survival after surgery for esophageal adenocarcinoma. The results showed that patients with complete LN regression, partial LN regression, or negative LNs had a lower mortality rate compared to those with poor/no LN regression.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Review Oncology

Is System xc- a Suitable Target for Tumour Detection and Response Assessment with Imaging?

Amy R. Sharkey, Timothy H. Witney, Gary J. R. Cook

Summary: This review summarizes the use of F-18-FSPG as a radiotracer in cancer patients. Although limited in number and with contrasting findings, the studies suggest a potential application of F-18-FSPG in assessing early treatment response and predicting treatment resistance.

CANCERS (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Weakly supervised segmentation models as explainable radiological classifiers for lung tumour detection on CT images

Robert O'Shea, Thubeena Manickavasagar, Carolyn Horst, Daniel Hughes, James Cusack, Sophia Tsoka, Gary Cook, Vicky Goh

Summary: Interpretability is essential for reliable CNN image classifiers in radiological applications. This study applies weakly supervised segmentation to generate explainable image classifiers, achieving precise localization of lung tumors trained with only image-level labels.

INSIGHTS INTO IMAGING (2023)

暂无数据